XRAY Dentsply SironaWatchlist
Dentsply Sirona News
Insiders Buying DENTSPLY SIRONA And 2 Other Stocks
Although U.S. stocks closed lower on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stoc
Should You Investigate DENTSPLY SIRONA Inc. (NASDAQ:XRAY) At US$31.48?
DENTSPLY SIRONA Inc. (NASDAQ:XRAY), is not the largest company out there, but it saw a double-digit share price rise of over 10% in the past couple of months on the NASDAQGS. As a mid-cap stock
Dentsply Sirona(XRAY.US) Director Buys US$314.4K in Common Stocks
$Dentsply Sirona(XRAY.US)$ Director LUCIER GREGORY T purchased 10,000 shares of Common Stocks on Nov 22, 2023 at an average price of $31.44 for a total value of $314.4K.Source: Announcement What is st
Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Have Hit The Brakes
Top Gap Ups and Downs on Tuesday: QCOM, LOW, MDT and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
Executive VP & CFO Glenn Coleman's Strategic Stake Increase in Dentsply Sirona Inc (XRAY)
Dentsply Sirona(XRAY.US) Officer Buys US$297K in Common Stocks
$Dentsply Sirona(XRAY.US)$ Officer Coleman Glenn purchased 10,000 shares of Common Stocks on Nov 20, 2023 at an average price of $29.7 for a total value of $297K. This transaction involves other relat
Dentsply Sirona Insider Bought Shares Worth $297,000, According to a Recent SEC Filing
Simon D Campion, Director, President, CEO & Member of BOD, on November 20, 2023, executed a purchase for 10,000 shares in Dentsply Sirona (XRAY) for $297,000. Following the Form 4 filing with the SEC,
Dentsply Sirona Sees a Couple of Insider Buys From CEO, CFO
Needham: The dental market has huge opportunities but may be limited in the short term by macroeconomic factors such as high interest rates
Investment bank Needham published a research report saying that although the dental products and equipment market seems to have huge opportunities, macroeconomic factors such as high interest rates and fluctuations in consumer spending may limit the growth of this market in the short term.
This Dental Equipment Maker Has Visible EPS Growth Despite A Challenging Macro: Analyst
Needham initiated coverage on Dentsply Sirona Inc (NASDAQ:XRAY), citing its third turnaround effort since the 2016 Dentsply-Sirona merger. Under prior management, Dentsply Sirona improved its product
DS Core Feature Updates: Smart Controlled Workflows, Excellent Patient Communication, and Advanced Collaboration With Partners
Analysts Are Bullish on These Healthcare Stocks: Cytek Biosciences (CTKB), DENTSPLY SIRONA (XRAY)
Stifel Maintains Hold on Dentsply Sirona, Lowers Price Target to $32
Stifel analyst Jonathan Block maintains Dentsply Sirona (NASDAQ:XRAY) with a Hold and lowers the price target from $35 to $32.
Buy Rating for DENTSPLY SIRONA: Projected Growth, Margin Expansion, and Significant Return to Shareholders
Dentsply Sirona to Participate in Upcoming Investor Conferences
CHARLOTTE, N.C., Nov. 10, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced its participation at upcoming conferences. Jefferies 2023 London
Analysts Have Conflicting Sentiments on These Healthcare Companies: DENTSPLY SIRONA (XRAY), GoodRx Holdings (GDRX) and Achieve Life Sciences (ACHV)
Loss-making DENTSPLY SIRONA (NASDAQ:XRAY) Sheds a Further US$273m, Taking Total Shareholder Losses to 42% Over 3 Years
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But if you try your hand at stock picking, your risk returning less th
Piper Sandler Sticks to Its Hold Rating for DENTSPLY SIRONA (XRAY)
Jefferies Firm Forecasts Promising Future and Double-Digit EPS Growth for DENTSPLY SIRONA: A Buy Rating Recommendation